BSEChandra Bhagat Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 22 Oct, 2026 · 12:29 IST

Board allots 6.6 million convertible warrants at Rs 44

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

The board allotted 6.6 million convertible warrants to nine investors, including seven promoter-group investors, at Rs 44 each. It reports Rs 7.26 crore received, but Rs 44 times 6.6 million equals Rs 29.04 crore. Each warrant can convert into one share within 18 months or lapse if unused.

Likely market impact

The funding can support growth, but conversion may increase the share count and reduce existing ownership. The stated payment needs clarification.